Christina Coughlin
2020
In 2020, Christina Coughlin earned a total compensation of $2.5M as Chief Medical Officer at Rubius Therapeutics.
Compensation breakdown
| Bonus | $216,476 |
|---|---|
| Option Awards | $1,828,388 |
| Salary | $420,369 |
| Other | $58,242 |
| Total | $2,523,475 |
Coughlin received $1.8M in option awards, accounting for 72% of the total pay in 2020.
Coughlin also received $216.5K in bonus, $420.4K in salary and $58.2K in other compensation.
Rankings
In 2020, Christina Coughlin's compensation ranked 4,508th out of 13,090 executives tracked by ExecPay. In other words, Coughlin earned more than 65.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,508 out of 13,090 | 66th |
Division Manufacturing | 1,821 out of 5,618 | 68th |
Major group Chemicals And Allied Products | 705 out of 2,251 | 69th |
Industry group Drugs | 604 out of 1,951 | 69th |
Industry Biological Products, Except Diagnostic Substances | 141 out of 411 | 66th |
Source: SEC filing on March 30, 2021.
Coughlin's colleagues
We found three more compensation records of executives who worked with Christina Coughlin at Rubius Therapeutics in 2020.